Related Experiment Videos
Dementia in Parkinson's disease.
Gregory A Rippon1, Karen S Marder
1Department of Neurology, Columbia University, New York, New York, USA.
Advances in Neurology
|December 31, 2005
Summary
Dementia in Parkinson disease (PDD) significantly impacts quality of life and prognosis. Current PDD treatments are symptomatic, highlighting the need for research into underlying disease mechanisms.
Area of Science:
- Neuroscience
- Neurology
- Gerontology
Background:
- Dementia is a key feature of idiopathic Parkinson disease (PD), affecting quality of life, prognosis, and management.
- The pathophysiology involves multifactorial processes affecting subcortical and cortical neuronal populations.
- This leads to a cognitive profile characterized by a dysexecutive syndrome.
Purpose of the Study:
- To summarize the current understanding of dementia in Parkinson disease (PDD).
- To highlight the clinical implications of PDD.
- To identify areas for future research in PDD.
Main Methods:
- Review of existing literature on Parkinson disease dementia (PDD).
- Analysis of the cognitive profile associated with PDD.
- Discussion of current therapeutic approaches and future research directions.
Main Results:
- PDD is characterized by a dysexecutive syndrome due to multifactorial neuronal derangement.
- Current treatments for PDD are symptomatic.
- The relationship between PDD, dementia with Lewy bodies (DLB), and Alzheimer disease (AD) requires further elucidation.
Conclusions:
- Dementia in Parkinson disease necessitates further research for targeted therapies.
- Understanding the underlying disease process is crucial for developing effective treatments.
- Elucidating the links between PDD, DLB, and AD is essential for advancing therapeutic strategies.